Why the study?
Impaired global longitudinal strain may be a valuable biomarker for early left ventricle impairment to help identify asymptomatic aortic stenosis patients at high risk of adverse outcomes.
Does impaired global longitudinal strain predict major adverse cardiovascular events in patients with asymptomatic aortic stenosis?
Does impaired global longitudinal strain predict major adverse cardiovascular events in patients with asymptomatic aortic stenosis?
Impaired global longitudinal strain is a significant predictor of major adverse cardiovascular events, all-cause mortality, and the need for aortic valve replacement in patients with asymptomatic aortic stenosis.
Answers are grounded in this paper and cite their sources.
Impaired GLS may refine risk stratification in asymptomatic AS; leaves open whether routine use improves outcomes.
Backgrounds The presence of impaired global longitudinal strain (GLS) may be a valuable bio-marker in the early diagnosis for left ventricle (LV) impairment, which would help scrutinize asymptomatic aortic stenosis (AS) patients with high risk of adverse outcomes, such as major adverse cardiovascular events (MACE). Methods The study was prospectively registered in PROPSERO (CRD 42021223472). Databases, such as Pubmed, Embase, Cochrane Library, Web of science, and Scopus were searched for studies evaluating the impact of impaired GLS on MACE, all-cause mortality, and aortic valve replacement (AVR) in asymptomatic AS. Hazard ratios ( HR s) with 95% CI s were calculated with meta-analysis for binary variants. Meta-regression, subgroup analysis, and sensitivity analyses were applied as needed to explore the heterogeneity. Results Eventually, a total of nine studies reporting 1,512 patients were enrolled. Compared with the normal GLS group, impaired GLS significantly increased MACE ( HR = 1.20, 95% CI : 1.10–1.30, I 2 = 79%) with evident heterogeneity, all-cause mortality ( HR = 1.42, 95% CI : 1.24–1.63), and AVR ( HR = 1.17, 95% CI : 1.07–1.28). Subgroup analyses stratified by left ventricular ejection fraction (LVEF) > 50% or LVEF without precise cut-off point found that compared with the normal GLS group, impaired GLS remarkably increased MACE both in two subgroups (LVEF > 50%: HR : 1.22, 95% CI : 1.05–1.50; LVEF without cutpoint: HR : 1.25, 95% CI : 1.05–1.50). The results stratified by AS severity (mild/moderate and severe) or follow-up time resembled those stratified by LVEF. In addition, when subgroup analysis was stratified by mean aortic valve pressure gradient (MG ≥ 40 mm Hg and MG <40 mm Hg), compared with normal GLS, impaired GLS significantly increased MACE both in two subgroups (MG ≥ 40 mm Hg: HR : 3.41, 95% CI : 1.64–7.09; MG below 40 mm Hg: HR : 3.17, 95% CI : 1.87–5.38). Moreover, the effect sizes here were substantially higher than those in the former two stratified factors. Conclusions The presence of impaired GLS substantially worsens the outcomes for adverse cardiovascular events in asymptomatic patients with AS regardless of LVEF or AS severity or follow-up time or mean aortic valve pressure gradient, which highlights the importance of incorporating impaired GLS into risk algorithms in asymptomatic AS. Systematic Review Registration PROSPERO (registration number: CRD42021223472).
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: